Matches in Wikidata for { <http://www.wikidata.org/entity/Q79343207> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q79343207 description "article scientifique (publié 2006)" @default.
- Q79343207 description "artikull shkencor i botuar më 01 janar 2006" @default.
- Q79343207 description "artículu científicu espublizáu en xineru de 2006" @default.
- Q79343207 description "im Jahr 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q79343207 description "scientific article published on 01 January 2006" @default.
- Q79343207 description "wetenschappelijk artikel" @default.
- Q79343207 description "наукова стаття, опублікована в січні 2006" @default.
- Q79343207 name "[The importance of micronization in the design of dosage forms II. Pharmaceutical technological considerations]" @default.
- Q79343207 name "[The importance of micronization in the design of dosage forms II. Pharmaceutical technological considerations]" @default.
- Q79343207 name "[The importance of micronization in the design of dosage forms II. Pharmaceutical technological considerations]" @default.
- Q79343207 type Item @default.
- Q79343207 label "[The importance of micronization in the design of dosage forms II. Pharmaceutical technological considerations]" @default.
- Q79343207 label "[The importance of micronization in the design of dosage forms II. Pharmaceutical technological considerations]" @default.
- Q79343207 label "[The importance of micronization in the design of dosage forms II. Pharmaceutical technological considerations]" @default.
- Q79343207 prefLabel "[The importance of micronization in the design of dosage forms II. Pharmaceutical technological considerations]" @default.
- Q79343207 prefLabel "[The importance of micronization in the design of dosage forms II. Pharmaceutical technological considerations]" @default.
- Q79343207 prefLabel "[The importance of micronization in the design of dosage forms II. Pharmaceutical technological considerations]" @default.
- Q79343207 P1433 Q79343207-C0EF2691-CCE2-4A48-96AA-9F77A6A7AC4F @default.
- Q79343207 P1476 Q79343207-679C9385-5094-4D88-8DCA-80B2F4B6D18D @default.
- Q79343207 P2093 Q79343207-27D2975C-A6D7-4034-B056-C3732C667665 @default.
- Q79343207 P304 Q79343207-9B375A35-4D67-421A-BE35-690F1F91E399 @default.
- Q79343207 P31 Q79343207-0E12F097-62E5-45EE-A4BE-223756F22E9D @default.
- Q79343207 P433 Q79343207-D18A47CF-E2CF-41A1-ABB9-BCE02E0AC400 @default.
- Q79343207 P478 Q79343207-95ABE782-974F-4FCB-A127-BD956051C22F @default.
- Q79343207 P577 Q79343207-C56C4827-77D2-47C1-BCF8-99D6AD973E31 @default.
- Q79343207 P698 Q79343207-849ECB4A-4FE6-46EE-BB44-AAEC22E2462D @default.
- Q79343207 P698 17094663 @default.
- Q79343207 P1433 Q15750084 @default.
- Q79343207 P1476 "[The importance of micronization in the design of dosage forms II. Pharmaceutical technological considerations]" @default.
- Q79343207 P2093 "István Antal" @default.
- Q79343207 P304 "149-154" @default.
- Q79343207 P31 Q13442814 @default.
- Q79343207 P433 "3" @default.
- Q79343207 P478 "76" @default.
- Q79343207 P577 "2006-01-01T00:00:00Z" @default.
- Q79343207 P698 "17094663" @default.